155 related articles for article (PubMed ID: 12929087)
1. Conditional knockout of the mouse NADPH-cytochrome p450 reductase gene.
Wu L; Gu J; Weng Y; Kluetzman K; Swiatek P; Behr M; Zhang QY; Zhuo X; Xie Q; Ding X
Genesis; 2003 Aug; 36(4):177-81. PubMed ID: 12929087
[TBL] [Abstract][Full Text] [Related]
2. Transgenic mice with a hypomorphic NADPH-cytochrome P450 reductase gene: effects on development, reproduction, and microsomal cytochrome P450.
Wu L; Gu J; Cui H; Zhang QY; Behr M; Fang C; Weng Y; Kluetzman K; Swiatek PJ; Yang W; Kaminsky L; Ding X
J Pharmacol Exp Ther; 2005 Jan; 312(1):35-43. PubMed ID: 15328377
[TBL] [Abstract][Full Text] [Related]
3. Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase.
Gu J; Weng Y; Zhang QY; Cui H; Behr M; Wu L; Yang W; Zhang L; Ding X
J Biol Chem; 2003 Jul; 278(28):25895-901. PubMed ID: 12697746
[TBL] [Abstract][Full Text] [Related]
4. Hepatic gene expression changes in mouse models with liver-specific deletion or global suppression of the NADPH-cytochrome P450 reductase gene. Mechanistic implications for the regulation of microsomal cytochrome P450 and the fatty liver phenotype.
Weng Y; DiRusso CC; Reilly AA; Black PN; Ding X
J Biol Chem; 2005 Sep; 280(36):31686-98. PubMed ID: 16006652
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 reductase dependent inhibition of cytochrome P450 2B1 activity: Implications for gene directed enzyme prodrug therapy.
Lengler J; Omann M; Düvier D; Holzmüller H; Gregor W; Salmons B; Günzburg WH; Renner M
Biochem Pharmacol; 2006 Sep; 72(7):893-901. PubMed ID: 16887103
[TBL] [Abstract][Full Text] [Related]
6. A mouse model with liver-specific deletion and global suppression of the NADPH-cytochrome P450 reductase gene: characterization and utility for in vivo studies of cyclophosphamide disposition.
Gu J; Chen CS; Wei Y; Fang C; Xie F; Kannan K; Yang W; Waxman DJ; Ding X
J Pharmacol Exp Ther; 2007 Apr; 321(1):9-17. PubMed ID: 17218484
[TBL] [Abstract][Full Text] [Related]
7. Role of small intestinal cytochromes p450 in the bioavailability of oral nifedipine.
Zhang QY; Kaminsky LS; Dunbar D; Zhang J; Ding X
Drug Metab Dispos; 2007 Sep; 35(9):1617-23. PubMed ID: 17567730
[TBL] [Abstract][Full Text] [Related]
8. Generation of a mouse model with a reversible hypomorphic cytochrome P450 reductase gene: utility for tissue-specific rescue of the reductase expression, and insights from a resultant mouse model with global suppression of P450 reductase expression in extrahepatic tissues.
Wei Y; Zhou X; Fang C; Li L; Kluetzman K; Yang W; Zhang QY; Ding X
J Pharmacol Exp Ther; 2010 Jul; 334(1):69-77. PubMed ID: 20375200
[TBL] [Abstract][Full Text] [Related]
9. Generation of a conditional allele of the mouse prostaglandin EP4 receptor.
Schneider A; Guan Y; Zhang Y; Magnuson MA; Pettepher C; Loftin CD; Langenbach R; Breyer RM; Breyer MD
Genesis; 2004 Sep; 40(1):7-14. PubMed ID: 15354288
[TBL] [Abstract][Full Text] [Related]
10. Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene.
Ma W; Tessarollo L; Hong SB; Baba M; Southon E; Back TC; Spence S; Lobe CG; Sharma N; Maher GW; Pack S; Vortmeyer AO; Guo C; Zbar B; Schmidt LS
Cancer Res; 2003 Sep; 63(17):5320-8. PubMed ID: 14500363
[TBL] [Abstract][Full Text] [Related]
11. The hepatic cytochrome P450 reductase null mouse as a tool to identify a successful candidate entity.
Henderson CJ; Pass GJ; Wolf CR
Toxicol Lett; 2006 Mar; 162(1):111-7. PubMed ID: 16343823
[TBL] [Abstract][Full Text] [Related]
12. Determination of the role of target tissue metabolism in lung carcinogenesis using conditional cytochrome P450 reductase-null mice.
Weng Y; Fang C; Turesky RJ; Behr M; Kaminsky LS; Ding X
Cancer Res; 2007 Aug; 67(16):7825-32. PubMed ID: 17699788
[TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of the NADPH cytochrome P450 reductase gene (CPR) from Candida bombicola.
Van Bogaert IN; Develter D; Soetaert W; Vandamme EJ
FEMS Yeast Res; 2007 Sep; 7(6):922-8. PubMed ID: 17559413
[TBL] [Abstract][Full Text] [Related]
14. Recombinant production of human microsomal cytochrome P450 2D6 in the methylotrophic yeast Pichia pastoris.
Dietrich M; Grundmann L; Kurr K; Valinotto L; Saussele T; Schmid RD; Lange S
Chembiochem; 2005 Nov; 6(11):2014-22. PubMed ID: 16222729
[TBL] [Abstract][Full Text] [Related]
15. Generation of a floxed allele of Smad5 for cre-mediated conditional knockout in the mouse.
Umans L; Vermeire L; Francis A; Chang H; Huylebroeck D; Zwijsen A
Genesis; 2003 Sep; 37(1):5-11. PubMed ID: 14502571
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 3A, NADPH cytochrome P450 reductase and cytochrome b5 in the upper airways in horse.
Tydén E; Olsén L; Tallkvist J; Tjälve H; Larsson P
Res Vet Sci; 2008 Aug; 85(1):80-5. PubMed ID: 17980394
[TBL] [Abstract][Full Text] [Related]
17. Discrimination of haptens from prohaptens using the metabolically deficient Cpr(low/low) mouse.
Chipinda I; Blachere FM; Anderson SE; Siegel PD
Toxicol Appl Pharmacol; 2011 May; 252(3):268-72. PubMed ID: 21376747
[TBL] [Abstract][Full Text] [Related]
18. Relationship between hepatic phenotype and changes in gene expression in cytochrome P450 reductase (POR) null mice.
Wang XJ; Chamberlain M; Vassieva O; Henderson CJ; Wolf CR
Biochem J; 2005 Jun; 388(Pt 3):857-67. PubMed ID: 15717863
[TBL] [Abstract][Full Text] [Related]
19. A transgenic mouse expressing human CYP4B1 in the liver.
Imaoka S; Hayashi K; Hiroi T; Yabusaki Y; Kamataki T; Funae Y
Biochem Biophys Res Commun; 2001 Jun; 284(3):757-62. PubMed ID: 11396967
[TBL] [Abstract][Full Text] [Related]
20. Establishment of conditional knockout alleles for the gene encoding the regulator of telomere length (RTEL).
Wu X; Sandhu S; Ding H
Genesis; 2007 Dec; 45(12):788-92. PubMed ID: 18064678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
